M42 announces new clinical LLM to transform the future of AI in healthcare 

M42 announces new clinical LLM to transform the future of AI in healthcare 

M42, a global tech-enabled healthcare network, has unveiled an advancement in healthcare technology with the launch of Med42, a new open-access Clinical Large Language Model (LLM). The 70 billion parameter, generative Artificial Intelligence (AI) model is poised to transform the future of AI across the healthcare sector and create a direct impact on patient care outcomes.  

Med42 provides high-quality answers to short and long-form medical questions. The model has been developed to exponentially enhance clinical decision-making and increase access to synthesized medical knowledge for healthcare professionals, patients and medical researchers through to regulators.  

Med42 was trained using M42’s industry-leading curated dataset of medical knowledge. When tested on multiple healthcare-relevant datasets, the model outperforms larger closed models, like ChatGPT 3.5, and achieves a 72% score, in a zero-shot evaluation, on the United States Medical Licensing Examination (USMLE) Sample Exam questions. 

Developed by M42’s Abu Dhabi-based team, Med42 was trained and fine-tuned with Cerebras in collaboration with Core42, a G42 company focused on enabling the delivery of national-scale AI and Enterprise AI programmes. A team from Mohamed bin Sayed University of Artificial Intelligence (MBSUAI) further evaluated the accuracy of the model. 

Hasan Jasem Al Nowais, Managing Director and Group Chief Executive Officer of M42, said: “Med42 will accelerate global access to healthcare knowledge and embodies our commitment to making a transformative impact across the healthcare sector. M42 is pushing the boundaries of healthcare innovation and charting a path towards more personalised, patient-centric care. The unique combination of M42’s world-class healthcare expertise and cutting-edge medical technologies allows us to impactfully contribute to the future of AI in healthcare – a future where AI is accessible to all while being rooted in ethics and prioritising the safety of users.” 

Al Nowais added: “The launch of Med42 firmly establishes and demonstrates the United Arab Emirates’ prominent standing in the global generative AI space. We are grateful for the support from the Abu Dhabi Department of Health and Abu Dhabi’s wider technology ecosystem.” 

Med42 has the potential to revolutionise the pace of clinical decision-making, acting as an AI assistant for healthcare professionals. The capability of the model extends to developing personalised treatment plans by analysing a patient’s medical history to identify the best course of treatment. Other use cases include helping doctors access insights faster, pharmacists decide on correct dosages, and supporting scientists studying treatment options to review literature efficiently.” 

Click below to share this article